Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Anti-inflammatory Therapy Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Anti-inflammatory Therapy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Corticosteroids
    • 1.2.3 Anti-inflammatory Biologics
    • 1.2.4 Non-Steroidal Anti-inflammatory Drugs
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Anti-inflammatory Therapy Market Share by Application: 2020 VS 2026
    • 1.3.2 Respiratory Diseases
    • 1.3.3 Arthritis
    • 1.3.4 Gastroenterology
    • 1.3.5 Dermatology
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Anti-inflammatory Therapy Market Perspective (2015-2026)
  • 2.2 Global Anti-inflammatory Therapy Growth Trends by Regions
    • 2.2.1 Anti-inflammatory Therapy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Anti-inflammatory Therapy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Anti-inflammatory Therapy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Anti-inflammatory Therapy Players by Market Size
    • 3.1.1 Global Top Anti-inflammatory Therapy Players by Revenue (2015-2020)
    • 3.1.2 Global Anti-inflammatory Therapy Revenue Market Share by Players (2015-2020)
  • 3.2 Global Anti-inflammatory Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Anti-inflammatory Therapy Revenue
  • 3.4 Global Anti-inflammatory Therapy Market Concentration Ratio
    • 3.4.1 Global Anti-inflammatory Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapy Revenue in 2019
  • 3.5 Key Players Anti-inflammatory Therapy Area Served
  • 3.6 Key Players Anti-inflammatory Therapy Product Solution and Service
  • 3.7 Date of Enter into Anti-inflammatory Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-inflammatory Therapy Breakdown Data by Type (2015-2026)

  • 4.1 Global Anti-inflammatory Therapy Historic Market Size by Type (2015-2020)
  • 4.2 Global Anti-inflammatory Therapy Forecasted Market Size by Type (2021-2026)

5 Anti-inflammatory Therapy Breakdown Data by Application (2015-2026)

  • 5.1 Global Anti-inflammatory Therapy Historic Market Size by Application (2015-2020)
  • 5.2 Global Anti-inflammatory Therapy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Anti-inflammatory Therapy Market Size (2015-2026)
  • 6.2 North America Anti-inflammatory Therapy Market Size by Type (2015-2020)
  • 6.3 North America Anti-inflammatory Therapy Market Size by Application (2015-2020)
  • 6.4 North America Anti-inflammatory Therapy Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Anti-inflammatory Therapy Market Size (2015-2026)
  • 7.2 Europe Anti-inflammatory Therapy Market Size by Type (2015-2020)
  • 7.3 Europe Anti-inflammatory Therapy Market Size by Application (2015-2020)
  • 7.4 Europe Anti-inflammatory Therapy Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Anti-inflammatory Therapy Market Size (2015-2026)
  • 8.2 China Anti-inflammatory Therapy Market Size by Type (2015-2020)
  • 8.3 China Anti-inflammatory Therapy Market Size by Application (2015-2020)
  • 8.4 China Anti-inflammatory Therapy Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Anti-inflammatory Therapy Market Size (2015-2026)
  • 9.2 Japan Anti-inflammatory Therapy Market Size by Type (2015-2020)
  • 9.3 Japan Anti-inflammatory Therapy Market Size by Application (2015-2020)
  • 9.4 Japan Anti-inflammatory Therapy Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Anti-inflammatory Therapy Market Size (2015-2026)
  • 10.2 Southeast Asia Anti-inflammatory Therapy Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Anti-inflammatory Therapy Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Anti-inflammatory Therapy Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 AbbVie
    • 11.1.1 AbbVie Company Details
    • 11.1.2 AbbVie Business Overview
    • 11.1.3 AbbVie Anti-inflammatory Therapy Introduction
    • 11.1.4 AbbVie Revenue in Anti-inflammatory Therapy Business (2015-2020))
    • 11.1.5 AbbVie Recent Development
  • 11.2 Johnson & Johnson
    • 11.2.1 Johnson & Johnson Company Details
    • 11.2.2 Johnson & Johnson Business Overview
    • 11.2.3 Johnson & Johnson Anti-inflammatory Therapy Introduction
    • 11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapy Business (2015-2020)
    • 11.2.5 Johnson & Johnson Recent Development
  • 11.3 Amgen Inc
    • 11.3.1 Amgen Inc Company Details
    • 11.3.2 Amgen Inc Business Overview
    • 11.3.3 Amgen Inc Anti-inflammatory Therapy Introduction
    • 11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapy Business (2015-2020)
    • 11.3.5 Amgen Inc Recent Development
  • 11.4 AstraZeneca PLC
    • 11.4.1 AstraZeneca PLC Company Details
    • 11.4.2 AstraZeneca PLC Business Overview
    • 11.4.3 AstraZeneca PLC Anti-inflammatory Therapy Introduction
    • 11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapy Business (2015-2020)
    • 11.4.5 AstraZeneca PLC Recent Development
  • 11.5 Pfizer, Inc
    • 11.5.1 Pfizer, Inc Company Details
    • 11.5.2 Pfizer, Inc Business Overview
    • 11.5.3 Pfizer, Inc Anti-inflammatory Therapy Introduction
    • 11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapy Business (2015-2020)
    • 11.5.5 Pfizer, Inc Recent Development
  • 11.6 Novartis
    • 11.6.1 Novartis Company Details
    • 11.6.2 Novartis Business Overview
    • 11.6.3 Novartis Anti-inflammatory Therapy Introduction
    • 11.6.4 Novartis Revenue in Anti-inflammatory Therapy Business (2015-2020)
    • 11.6.5 Novartis Recent Development
  • 11.7 Roche
    • 11.7.1 Roche Company Details
    • 11.7.2 Roche Business Overview
    • 11.7.3 Roche Anti-inflammatory Therapy Introduction
    • 11.7.4 Roche Revenue in Anti-inflammatory Therapy Business (2015-2020)
    • 11.7.5 Roche Recent Development
  • 11.8 Merck
    • 11.8.1 Merck Company Details
    • 11.8.2 Merck Business Overview
    • 11.8.3 Merck Anti-inflammatory Therapy Introduction
    • 11.8.4 Merck Revenue in Anti-inflammatory Therapy Business (2015-2020)
    • 11.8.5 Merck Recent Development
  • 11.9 Sanofi
    • 11.9.1 Sanofi Company Details
    • 11.9.2 Sanofi Business Overview
    • 11.9.3 Sanofi Anti-inflammatory Therapy Introduction
    • 11.9.4 Sanofi Revenue in Anti-inflammatory Therapy Business (2015-2020)
    • 11.9.5 Sanofi Recent Development
  • 11.10 GlaxoSmithKline
    • 11.10.1 GlaxoSmithKline Company Details
    • 11.10.2 GlaxoSmithKline Business Overview
    • 11.10.3 GlaxoSmithKline Anti-inflammatory Therapy Introduction
    • 11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapy Business (2015-2020)
    • 11.10.5 GlaxoSmithKline Recent Development
  • 11.11 Sun Pharmaceutical Industries Ltd
    • 10.11.1 Sun Pharmaceutical Industries Ltd Company Details
    • 10.11.2 Sun Pharmaceutical Industries Ltd Business Overview
    • 10.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Introduction
    • 10.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapy Business (2015-2020)
    • 10.11.5 Sun Pharmaceutical Industries Ltd Recent Development
  • 11.12 TEVA
    • 10.12.1 TEVA Company Details
    • 10.12.2 TEVA Business Overview
    • 10.12.3 TEVA Anti-inflammatory Therapy Introduction
    • 10.12.4 TEVA Revenue in Anti-inflammatory Therapy Business (2015-2020)
    • 10.12.5 TEVA Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Market Analysis and Insights: Global Anti-inflammatory Therapy Market
    The global Anti-inflammatory Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
    With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-inflammatory Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-inflammatory Therapy market in terms of revenue.
    On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-inflammatory Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-inflammatory Therapy market.
    Anti-inflammatory Therapy Breakdown Data by Type
    Corticosteroids
    Anti-inflammatory Biologics
    Non-Steroidal Anti-inflammatory Drugs
    Others
    Anti-inflammatory Therapy Breakdown Data by Application
    Respiratory Diseases
    Arthritis
    Gastroenterology
    Dermatology
    Others
    Based on regional and country-level analysis, the Anti-inflammatory Therapy market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa
    In the competitive analysis section of the report, leading as well as prominent players of the global Anti-inflammatory Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The following players are covered in this report:
    AbbVie
    Johnson & Johnson
    Amgen Inc
    AstraZeneca PLC
    Pfizer, Inc
    Novartis
    Roche
    Merck
    Sanofi
    GlaxoSmithKline
    Sun Pharmaceutical Industries Ltd
    TEVA

    Buy now